Trademark: 90681693
Word
ANGITIA
Status
Dead
Status Code
606
Status Date
Monday, April 24, 2023
Serial Number
90681693
Mark Type
3000
Filing Date
Thursday, April 29, 2021
Published for Opposition
Tuesday, July 26, 2022
Abandoned Date
Monday, April 24, 2023

Trademark Owner History

Classifications
5 Allergy tablets; Anti-inflammatory ointments; Anti-itch ointment; Antibiotic ointments; Antibiotic tablets; Biological tissue grafts; Bone cement for medical purposes; Bone cement for surgical and orthopaedic purposes; Bone growth media consisting of biological materials for medical purposes; Cement for bones for medical use; Ceramic materials for dental use for fillings; Drug delivery agents in the form of injections solutions that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of tablets that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of ointment suspensions that facilitate the delivery of pharmaceutical preparations; Hemorrhoidal ointments; Materials for dental fillings; Materials for dental fillings and for sealing purposes; Medical dressings; Medicated ointments for treating dermatological conditions; Medicated sunburn ointments; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Mentholated ointment for medical use; Mercurial ointments for medical use; Nutritional meal replacement bars adapted for medical use for individuals undergoing medical treatments; Nutritive substances for micro-organisms for medical use; Nutritive substances for microorganisms for medical purposes; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical preparations for the treatment of bone fractures; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Skin grafts; Synthetic materials for dental use for fillings; Thyroid and para-thyroid hormone preparations; Tumor suppressing agents; Vascular grafts; Veterinary pharmaceutical preparations for the prevention of cardiovascular disorders, immune disorders, infection, nervous system disorders; Veterinary pharmaceutical preparations for the treatment of cardiovascular disorders, immune disorders, infection, nervous system disorders, anxiety disorders, cancer; Veterinary preparations, namely, pain relief medication; Vitamin D preparations
The mark consists of the stylized wording "angitia" with 3 cloves above the stylized letters "iti" and 3 Chinese characters below the stylized wording.
The non-Latin characters in the mark transliterate to "an ji sheng" and this has no meaning in a foreign language.

Trademark Events
Apr 24, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 24, 2023
Abandonment - No Use Statement Filed
Sep 20, 2022
Noa E-Mailed - Sou Required From Applicant
Jul 26, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 26, 2022
Published For Opposition
Jul 6, 2022
Notification Of Notice Of Publication E-Mailed
Jun 21, 2022
Approved For Pub - Principal Register
Jun 20, 2022
Teas/Email Correspondence Entered
Jun 20, 2022
Correspondence Received In Law Office
Jun 20, 2022
Teas Response To Office Action Received
Jan 6, 2022
Notification Of Non-Final Action E-Mailed
Jan 6, 2022
Non-Final Action E-Mailed
Jan 6, 2022
Non-Final Action Written
Dec 28, 2021
Assigned To Examiner
Sep 10, 2021
Teas Change Of Correspondence Received
Sep 10, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 10, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 5, 2021
Notice Of Design Search Code E-Mailed
Aug 4, 2021
New Application Office Supplied Data Entered
May 3, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24